Skip to content
Solutions and training for Data Integrity, Data Governance, QMS, Laboratory Systems, Manufacturing Systems, and Medical Devices.
Solutions and training for Data Integrity, Data Governance, QMS, Laboratory Systems, Manufacturing Systems, and Medical Devices.
Data Integral Ltd are expert in providing Data Integrity, Data Governance, CSV, and project management solutions for companies engaged in the manufacture and testing of licenced medicinal products and Medical Devices.
  • Home
  • About Us
  • Services
  • Blog
  • Contact Us
  • FAQ
  • Our Experience
  • Gallery

Blog

AI is starting to impact drug discovery with use of pharmacokinetics models.

27 February 2020 danielmilek01

AI was always going to be of use in pharmacokinetics. Here it comes.

https://sifted.eu/articles/ai-transforming-pharma/?fbclid=IwAR3TSboG7VYnv7LNLl7ijarcSVubxoqG-1xp46ADibTck3e5tsTqn3SYSTU

Posted in: Artificial Intelligence

Post navigation

← T-cell discovery sounds promising for cancer treatment!
Revision of EudraLex Volume 4 annex 1 is available in draft and open for comment and contribution until 20 May 2020. →
  • Email
    enquiries@dataintegral.co.uk
  • Phone
    07503688863
  • Address
    NBV Enterprise Centre
    David Lane
    Nottingham
    NG6 0JU
  • Google+
  • LinkedIn

Incorporated in England and Wales |
Registration No. 10672594

Copyright © 2017 - 2024 Data Integral Ltd. All Rights Reserved.